Uridine cytidine kinases govern molnupiravir bioactivation and anti-SARS-CoV-2 activity
PLOS Pathogens · 29.05.2026 · 22 (5) · e1014225
DOI: 10.1371/journal.ppat.1014225 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 29.05.2026. Verfasst von Huazhang Shu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Pathology, Science for Life Laboratory (SciLifeLab), Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Cytidine, Uridine Kinase, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VetenskapsrÃ¥det, Cancerfonden, Barncancerfonden.
Abstract (Originalsprache)
Molnupiravir is a nucleoside analogue antiviral drug against RNA viruses, including its clinical indication SARS-CoV-2. Whilst its mechanism-of-action is well defined, host factors that regulate its therapeutic responses have not been thoroughly deciphered and characterized. Here we show that uridine cytidine kinases (UCKs), key enzymes in pyrimidine salvage, effectively phosphorylate and thereby bioactivate N4-hydroxycytidine (NHC) – the active compound of molnupiravir, thus dictating its anti-SARS-CoV-2 efficacy and furthermore selectivity. In vitro, both isoforms of UCKs (UCK1 and UCK2) effectively phosphorylated NHC, where the structural basis of the catalysis was further deciphered via the first complete substrate bound co-crystal structure of UCK, i.e., UCK1-NHC-AMPPNP. In SARS-CoV-2-infected cells, UCK2 knockdown via siRNA hampered the intracellular accumulation of the tri-phosphorylated antiviral metabolite of NHC, resulting in a 10-fold reduction of the antiviral efficacy, and surprisingly, 2-fold reduction of its selectivity, which were critically recapitulated in a dose-dependent manner using a pan-UCK inhibitor. Altogether, this work underscores UCKs as pivotal players in upholding molnupiravir efficacy and therapeutic window, and furthermore as pharmacologically tractable targets for tailoring the drug response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology-Pathology, Science for Life Laboratory (SciLifeLab), Karolinska Institutet, Stockholm, Sweden.
- Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
- Department of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
- Department of Laboratory Medicine, Division of Clinical Physiology, Karolinska Institutet Huddinge, Huddinge, Sweden.
- Department of Laboratory Medicine, Division of Clinical Physiology, Karolinska University Hospital, Huddinge, Sweden.
- Department of Oncology-Pathology, Precision Cancer Medicine, Karolinska Institutet, Science for Life Laboratory, Solna, Sweden.
ORCID-Profile: Si Min Zhang
Förderung
- Vetenskapsrådet
- Cancerfonden
- Barncancerfonden
- Karolinska Institutet
- Stiftelsen Felix Mindus Bidrag till Leukemiforskningen
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
- Ã…ke Wiberg Stiftelse
- Stiftelsen Lars Hiertas Minne
Zitieren
APA
Shu, H., Ludäscher, J. M., Sharma, S., Alam, S., Frank, L., Hutchinson, E. S., Tampere, M., Lévêque, C., van Kuilenburg, A. B. P., Valerie, N. C. K., Altun, M., Chabes, A., Stenmark, P., Rudd, S. G., & Zhang, S. M. (2026). Uridine cytidine kinases govern molnupiravir bioactivation and anti-SARS-CoV-2 activity. PLOS Pathogens, 22(5), e1014225. https://doi.org/10.1371/journal.ppat.1014225
Vancouver
Shu H, Ludäscher JM, Sharma S, Alam S, Frank L, Hutchinson ES, et al. Uridine cytidine kinases govern molnupiravir bioactivation and anti-SARS-CoV-2 activity. PLOS Pathogens. 2026;22(5):e1014225. doi:10.1371/journal.ppat.1014225
BibTeX
@article{Shu2026,
author = {Shu, Huazhang and Ludäscher, Julian M and Sharma, Sushma and Alam, Seher and Frank, Lilian and Hutchinson, Emma Scaletti and Tampere, Marianna and Lévêque, Chloé and van Kuilenburg, André B P and Valerie, Nicholas C K and Altun, Mikael and Chabes, Andrei and Stenmark, Pål and Rudd, Sean G and Zhang, Si Min},
title = {Uridine cytidine kinases govern molnupiravir bioactivation and anti-SARS-CoV-2 activity},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {5},
pages = {e1014225},
doi = {10.1371/journal.ppat.1014225}
}
EUVIMED